MedTrace Logo

Evaluation of the Effectiveness of The Volara System Determined by Sputum Movement and Production

NCT06937216 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-04-22

No results posted yet for this study

Summary

The aim of this study is to evaluate the therapeutic effect of therapy with The Volara System on mucus clearance.

Conditions

  • Bronchiectasis Adult
  • COPD

Interventions

DEVICE

Volara therapy

Oscillation and Lung Expansion (OLE) therapy, is a respiratory airway clearance intervention including continuous high-frequency oscillation and continuous positive expiratory pressure

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2025-09-30
Completion
2025-11-30
FDA Device
Yes

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06937216 on ClinicalTrials.gov